A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients | MicrobiomeTrials← Back to trialsNCT07644351
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients
CompletedOBSERVATIONAL
Trial Details
Start: 2024-12-16Est. Completion: 2025-09-17
Enrollment target: 37 participants Locations- Novartis Investigative Site, Boston, Massachusetts, United States
- Novartis Investigative Site, Sydney, New South Wales, Australia
- Novartis Investigative Site, Montreal, Canada
- Novartis Investigative Site, Hong Kong, China
- Novartis Investigative Site, Le Chesnay, France
- Novartis Investigative Site, Ramat Gan, Israel
- Novartis Investigative Site, Ascoli Piceno, Italy
- Novartis Investigative Site, Bari, Italy
- Novartis Investigative Site, Catania, Italy
- Novartis Investigative Site, Cuneo, Italy
- Novartis Investigative Site, Pescara, Italy
- Novartis Investigative Site, Torino, Italy
- Novartis Investigative Site, Rotterdam, Netherlands
- Novartis Investigative Site, Islamabad, Pakistan
- Novartis Investigative Site, Rawalpindi, Pakistan
- Novartis Investigative Site, Bialystok, Poland
- Novartis Investigative Site, Madrid, Spain
- Novartis Investigative Site, London, United Kingdom
Other microbiome trials you might be interested in
Acute Lymphoblastic Leukemia
The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medicat…
Chicago, United StatesEst. completion Jun 15, 2027
Acute Lymphoblastic LeukemiaB-All
Background:
Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy invol…
Bethesda, United StatesEst. completion Jan 31, 2030
Phase 1
Recruiting
B-cell Acute Lymphoblastic Leukemia
This is a single-center, open-label, single-arm prospective study designed to evaluate the safety, tolerability, and eff…
Beijing, ChinaEst. completion Dec 31, 2026